AP NEWS

DEADLINE MONDAY: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TGTX, ACHC and ADNT

December 2, 2018

NEW YORK, Dec. 02, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

TG Therapeutics, Inc. (NASDAQCM: TGTX) Class Period: June 4, 2018 to September 25, 2018 Lead Plaintiff Deadline: December 3, 2018

During the class period, TG Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) TG was involved in cleaning the data collected in the UNITY-CLL Trial; and as a result, was able to gain an understanding as to the efficacy of the combination therapy; (2) as a result of that data cleaning, TG knew the UNITY-CLL Trial had failed to meet its stated goal and as a result, the Company would not be able to seek accelerated approval; and (3) given that the UNITY-CLL Trial had failed to meet its stated goal, it was highly unlikely that the combination therapy would meet its primary endpoint of increased progression free survival.

Get additional information about the TGTX lawsuit: http://www.kleinstocklaw.com/pslra-1/tg-therapeutics-inc-loss-submission-form?wire=3

Acadia Healthcare Company, Inc. (NASDAQGS: ACHC) Class Period: February 23, 2017 to October 24, 2017 Lead Plaintiff Deadline: December 3, 2018

The complaint alleges Acadia Healthcare Company, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the quality of Acadia’s U.K. operations did not give the Company a “competitive strength” that would drive future growth and profitability; and (2) defendants had no reasonable basis to believe--and did not in fact believe--their positive statements about the Company’s business and financial prospects during the Class Period, including their guidance issued and reaffirmed throughout the Class Period.

Get additional information about the ACHC lawsuit: http://www.kleinstocklaw.com/pslra-1/acadia-healthcare-company-inc-loss-submission-form?wire=3

Adient plc (NYSE: ADNT) Class Period: October 31, 2016 to June 11, 2018 Lead Plaintiff Deadline: December 3, 2018

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements. In particular, the complaint alleges that defendants repeatedly stressed to investors that the Company was “solidly on track” to deliver 200-basis-point margin expansion by 2020, which was largely dependent on operational and financial improvements in Adient’s core SS&M business, while unbeknownst to investors, Adient’s core SS&M business faced significant operational problems such that the repeatedly touted 200-basis-point margin expansion was not “on track” at any point during the Class Period. Consequently, Adient stock traded at artificially inflated prices during the Class Period, reaching a high of $85.93 per share.

Get additional information about the ADNT lawsuit: http://www.kleinstocklaw.com/pslra-1/adient-plc-loss-submission-form?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:J. Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY 10118 jk@kleinstocklaw.com Telephone: (212) 616-4899Fax: (347) 558-9665 www.kleinstocklaw.com

AP RADIO
Update hourly